MERS (Middle East Respiratory Syndrome) — Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S
Citation(s)
An Open, Single Center Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-MERS-S